By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Five Prime Therapeutics, Inc. 

1650 Owens Street
Suite 200
San Francisco  California  94158  U.S.A.
Phone: 415-365-5600 Fax: 415-365-5601


SEARCH JOBS








Company News
J.P. Morgan: Five Prime Therapeutics, Inc. (FPRX) CEO Says Experimental Drug to Head Into Six New Tumor Trials Via Bristol-Myers Squibb Company (BMY) 1/15/2015 1:19:13 PM
Five Prime Therapeutics, Inc. (FPRX) Announces Closing Of Public Offering 1/12/2015 8:06:27 AM
Five Prime Therapeutics, Inc. (FPRX) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/9/2015 8:07:42 AM
Five Prime Therapeutics, Inc. (FPRX) Prices Public Offering Of Common Stock 1/7/2015 7:23:12 AM
Five Prime Therapeutics, Inc. (FPRX) Announces $75 Million Proposed Public Offering Of Common Stock 1/6/2015 7:50:32 AM
Five Prime Therapeutics, Inc. (FPRX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014 12:12:53 PM
Five Prime Therapeutics, Inc. (FPRX) Initiates Patient Dosing In Phase 1 Clinical Trial Evaluating FPA144 In Gastric Cancer 12/5/2014 9:50:43 AM
Five Prime Therapeutics, Inc. (FPRX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/26/2014 10:51:17 AM
Bristol-Myers Squibb Company (BMY) And Five Prime Therapeutics, Inc. (FPRX) Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types 11/24/2014 8:44:55 AM
Five Prime Therapeutics, Inc. (FPRX) Initiates Dosing Of Rheumatoid Arthritis Patients In Its Phase 1 Clinical Trial Of FPA008 11/17/2014 4:21:24 PM
123456789
//-->